By examining the direct, indirect, and intangible expenses, the goal is to gauge the illness burden and health economics of inpatients with multiple sclerosis in China. In 50 centres, a cross-sectional retrospective analysis covered a total of 863 patients. The cost of hospitalisation and medications used outside of hospitals were used to calculate the direct economic burden, and the human capital technique was used to calculate the indirect economic burden. The intangible economic cost was expressed in terms of the disability-adjusted life year. Calculating the incremental cost-utility ratio allowed for cost-utility analysis using DALYs as measures of health benefits.
KeywordsMultiple sclerosis; Disease burden; Health economics; Disability-adjusted life years
Published Date: 2023-01-31; Received Date: 2023-01-02
